{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:36:34Z","timestamp":1790436994762,"version":"4.1.0"},"reference-count":29,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,8,1]]},"DOI":"10.2169\/internalmedicine.4593-20","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T22:04:44Z","timestamp":1587593084000},"page":"1849-1853","source":"Crossref","is-referenced-by-count":6,"title":["Small Intestinal Bacterial Overgrowth Diagnosed by a Breath Test and Improved by Rifaximin in a Patient with Hepatic Encephalopathy and Alcoholic Liver Cirrhosis"],"prefix":"10.2169","volume":"59","author":[{"given":"Akira","family":"Sakamaki","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiko","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusako","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroteru","family":"Kamimura","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenya","family":"Kamimura","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Takamura","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Terai","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Saunders JB, Walters JR, Davies AP, Paton A. A 20-year prospective study of cirrhosis. Br Med J (Clin Res Ed) 282: 263-266, 1981.","DOI":"10.1136\/bmj.282.6260.263"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Romero-G\u00f3mez M, Boza F, Garc\u00eda-Valdecasas MS, Garc\u00eda E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 96: 2718-2723, 2001.","DOI":"10.1016\/S0002-9270(01)02692-2"},{"key":"3","unstructured":"3. Weissenborn K. Hepatic encephalopathy: definition, clinical grading and diagnostic principles. Drugs 79: 5-9, 2019."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bustamante J, Rimola A, Ventura PJ, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 30: 890-895, 1999.","DOI":"10.1016\/S0168-8278(99)80144-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Wijdicks EF. Hepatic encephalopathy. N Engl J Med 375: 1660-1670, 2016.","DOI":"10.1056\/NEJMra1600561"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cie\u0107ko-Michalska I, Szczepanek M, S\u0142owik A, Mach T. Pathogenesis of hepatic encephalopathy. Gastroenterol Res Pract 2012: 642108, 2012.","DOI":"10.1155\/2012\/642108"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35: 716-721, 2002.","DOI":"10.1053\/jhep.2002.31250"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol 60: 197-209, 2014.","DOI":"10.1016\/j.jhep.2013.07.044"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ghosh G, Jesudian AB. Small intestinal bacterial overgrowth in patients with cirrhosis. J Clin Exp Hepatol 9: 257-267, 2019.","DOI":"10.1016\/j.jceh.2018.08.006"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Choung RS, Ruff KC, Malhotra A, et al. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther 33: 1059-1067, 2011.","DOI":"10.1111\/j.1365-2036.2011.04625.x"},{"key":"11","unstructured":"11. Maslennikov R, Pavlov C, Ivashkin V. Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis. Hepatol Int 12: 567-576, 2018."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Bures J, Cyrany J, Kohoutova D, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol 16: 2978-2990, 2010.","DOI":"10.3748\/wjg.v16.i24.2978"},{"key":"13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/0016-5085(90)90818-L","volume":"98","author":"GR Corazza","year":"1990","unstructured":"13. Corazza GR, Menozzi MG, Strocchi A, et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology 98: 302-309, 1990.","journal-title":"Gastroenterology","ISSN":"https:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"14","unstructured":"14. Ghoshal UC, Ghoshal U, Das K, Misra A. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time. Indian J Gastroenterol 25: 6-10, 2006."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Vanuytsel T, Tack JF, Boeckxstaens GE. Treatment of abdominal pain in irritable bowel syndrome. J Gastroenterol 49: 1193-1205, 2014.","DOI":"10.1007\/s00535-014-0966-7"},{"key":"16","unstructured":"16. Esposito I, de Leone A, Di Gregorio G, et al. Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: an observation on non-absorbable antibiotics. World J Gastroenterol 13: 6016-6021, 2007."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Majewski M, Reddymasu SC, Sostarich S, Foran P, McCallum RW. Efficacy of rifaximin, a nonabsorbed oral antibiotic, in the treatment of small intestinal bacterial overgrowth. Am J Med Sci 333: 266-270, 2007.","DOI":"10.1097\/MAJ.0b013e3180536784"},{"key":"18","unstructured":"18. Peralta S, Cottone C, Doveri T, Almasio PL, Craxi A. Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin. World J Gastroenterol 15: 2628-2631, 2009."},{"key":"19","unstructured":"19. Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol 33: 550-558, 2015."},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology 60: 715-735, 2014.","DOI":"10.1002\/hep.27210"},{"key":"21","unstructured":"21. Rezaie A, Buresi M, Lembo A, et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the north american consensus. Am J Gastroenterol 112: 775-784, 2017."},{"key":"22","unstructured":"22. Kimer N, Krag A, M\u00f8ller S, Bendtsen F, Gluud LL. Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy. Aliment Pharmacol Ther 40: 123-132, 2014."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Bass NM, Mullen KD, Sanyal A, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med 362: 1071-1081, 2010.","DOI":"10.1056\/NEJMoa0907893"},{"key":"24","unstructured":"24. Zhang Y, Feng Y, Cao B, Tian Q. Effects of SIBO and rifaximin therapy on MHE caused by hepatic cirrhosis. Int J Clin Exp Med 8: 2954-2957, 2015."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kawaguchi T, Konishi M, Kato A, et al. Updating the neuropsychological test system in Japan for the elderly and in a modern touch screen tablet society by resetting the cut-off values. Hepatol Res 47: 1335-1339, 2017.","DOI":"10.1111\/hepr.12864"},{"key":"26","unstructured":"26. de Lacy Costello BP, Ledochowski M, Ratcliffe NM. The importance of methane breath testing: a review. J Breath Res 7: 024001, 2013."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Quigley EM, Abu-Shanab A. Small intestinal bacterial overgrowth. Infect Dis Clin North Am 24: 943-959, 2010.","DOI":"10.1016\/j.idc.2010.07.007"},{"key":"28","unstructured":"28. Bauer TM, Schwacha H, Steinbr\u00fcckner B, et al. Diagnosis of small intestinal bacterial overgrowth in patients with cirrhosis of the liver: poor performance of the glucose breath hydrogen test. J Hepatol 33: 382-386, 2000."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Sundin OH, Mendoza-Ladd A, Morales E, et al. Does a glucose-based hydrogen and methane breath test detect bacterial overgrowth in the jejunum? Neurogastroenterol Motil 30: e13350, 2018.","DOI":"10.1111\/nmo.13350"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/15\/59_4593-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T03:34:15Z","timestamp":1596252855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/15\/59_4593-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,1]]},"references-count":29,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4593-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,1]]}}}